US Patent 12071480 CD47 antibodies and uses thereof for treating cancer
Patent 12071480 was granted and assigned to Seagen on August, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 28 Aug, 2024
Golden AI
Edits made to:
Infobox (+32 properties)
Article (+393 characters)
US Patent 12071480 CD47 antibodies and uses thereof for treating cancer
Article
Patent abstract
Humanized antibodies, including masked antibodies that specifically bind to CD47 are provided. Methods for using anti-CD47 antibodies, including masked antibodies, to modulate activity of (e.g., inhibit proliferation of) a CD47-expressing cell, as well as for the treatment of one or more diseases or disorders (e.g., cancer) associated with CD47-expressing cells, are provided.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Che Leung-Law0
Christopher Carosino0
Lori Westendorf0
Matthew Levengood0
Michael Feldhaus0
Shyra Gardai0
Vivian Trang0
Date of Patent
August 27, 2024
0Patent Application Number
175059110
Date Filed
October 20, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12071480 CD47 antibodies and uses thereof for treating cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
